1335.70
5.70
(0.43%)
3.3M
NSE+BSE Volume
NSE 08 Apr, 2026 3:31 PM (IST)
Positive Trial
Aurobindo Pharma unit reports positive Phase 3 results for BP11, a drug for repeated skin allergies
See details